Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents-Reference-Cited by-同舟云学术

Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents

Published:2012-01 Issue:3 Volume:100 Page:398-403
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Kotagale Nandkishor R.,Taksande Brijesh G.,Wadhwani Paresh J.,Palhade Mahesh W.,Mendhi Sachin M.,Gawande Dinesh Y.,Hadole Pravin N.,Chopde Chandrabhan T.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference74 articles.

1. Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine;Alsene;Neuropsychopharmacology,2010

2. The side effects of antimalarial drugs indicate a polyamine involvement in both schizophrenia and depression;Andrews;Med Hypotheses,1985

3. Nitric oxide inhibits prolactin secretion in pituitary cells downstream of voltage-gated calcium influx;Andric;Endocrinol,2003

4. Is agmatine an endogenous anxiolytic/anti-depressant agent?;Aricioglu;Ann NY Acad Sci,2003

5. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats;Aricioglu-Kartal;Life Sci,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fluorescent biosensor for the visualization of agmatine;2024-07-27

2. Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-γ;Pharmacology Biochemistry and Behavior;2023-12

3. Neuroprotection by agmatine: Possible involvement of the gut microbiome?;Ageing Research Reviews;2023-11

4. Multi-Regulatory Effects of Agmatine on Akt/GSK-3β/β-Catenin Signaling Pathway in SH-SY5Y cells: A Potential Explanation for its Conflicting Roles in Schizophrenia;Psychiatry and Behavioral Sciences;2023

5. Chemogenetic activation of VGLUT3-expressing neurons decreases movement;European Journal of Pharmacology;2022-11